| Literature DB >> 32792582 |
Lais B Latorraca1, Weber B Feitosa2, Camila Mariano2, Marcelo T Moura2, Patrícia K Fontes1, Marcelo F G Nogueira1,3, Fabíola F Paula-Lopes4,5.
Abstract
Autophagy is a physiological mechanism that can be activated under stress conditions. However, the role of autophagy during oocyte maturation has been poorly investigated. Therefore, this study characterized the role of autophagy on developmental competence and gene expression of bovine oocytes exposed to heat shock (HS). Cumulus-oocyte-complexes (COCs) were matured at Control (38.5 °C) and HS (41 °C) temperatures in the presence of 0 and 10 mM 3-methyladenine (3MA; autophagy inhibitor). Western blotting analysis revealed that HS increased autophagy marker LC3-II/LC3-I ratio in oocytes. However, there was no effect of temperature for oocytes matured with 3MA. On cumulus cells, 3MA reduced LC3-II/LC3-I ratio regardless of temperature. Inhibition of autophagy during IVM of heat-shocked oocytes (3MA-41 °C) reduced cleavage and blastocyst rates compared to standard in vitro matured heat-shocked oocytes (IVM-41 °C). Therefore, the magnitude of HS detrimental effects was greater in the presence of autophagy inhibitor. Oocyte maturation under 3MA-41 °C reduced mRNA abundance for genes related to energy metabolism (MTIF3), heat shock response (HSF1), and oocyte maturation (HAS2 and GREM1). In conclusion, autophagy is a stress response induced on heat shocked oocytes. Inhibition of autophagy modulated key functional processes rendering the oocyte more susceptible to the deleterious effects of heat shock.Entities:
Mesh:
Substances:
Year: 2020 PMID: 32792582 PMCID: PMC7426922 DOI: 10.1038/s41598-020-69939-3
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
Figure 1Schematic representation of the experimental design. COCs underwent IVM at Control (38.5 °C for 22 h) and Heat Shock (41 °C for 16 h followed by 38.5 °C for 6 h) temperatures in the presence of 0 or 10 mM 3MA. After 22 h IVM, COCs were either denuded and processed for western blotting and RT-qPCR analysis or submitted to IVF for 18 h at 38.5°C, followed by IVC for 8 days. Embryonic development was recorded on Days 3 (cleavage rate, %) and 8 (blastocyst rate, %) after IVF. IVM, in vitro maturation; IVF, in vitro fertilization; IVC, in vitro culture; 3MA, 3-Methyladenine. The figure was
adapted from Master’s Thesis[83].
Genes evaluated by RT-qPCR using Applied BiosystemsTaqMan Assay[83].
| Gene ID | Initials | Full name |
|---|---|---|
| Bt03213473_m1 | AGTR1 | Angiotensin II receptor type 1 |
| AIY9Z3D | AGTR2 | Angiotensin II receptor type 2 |
| Bt03271014_m1 | AREG/LOC538751 | Amphiregulin |
| Bt03213774_m1 | ARO | Aromatase |
| Bt03221057_m1 | ATF4 | Activating transcription factor 4 |
| Bt03210836_g1 | ATP5L | ATP synthase, H + transporting, mitochondrial Fo complex subunit E |
| Bt03275798_m1 | AUH | AU RNA binding protein |
| Bt03251628_m1 | BAX | BCL2-Associated X Protein |
| Bt03211777_g1 | BCL2 | B-cell CLL/lymphoma 2 |
| Bt04298952_m1 | BID | BH3 interacting domain death agonist |
| Bt03241255_m1 | BMP15 | Bone morphogenetic protein 15 |
| Bt03286494_u1 | CASP3 | caspase 3, apoptosis-related cysteine peptidase |
| Bt03250954_g1 | CASP9 | Caspase 9, apoptosis-related cysteine peptidase |
| Bt04282453_m1 | CAT | Catalase |
| Bt03228713_m1 | CCND2 | Cyclin D2 |
| Bt03249250_m1 | CDCA8 | Cell division cycle associated 8 |
| Bt03257041_g1 | CDK6 | Cyclin-dependent kinase 6 |
| Bt04311264_m1 | DDIT3 | DNA-damage-inducible transcript 3 |
| Bt03251320_g1 | DICER1 | Dicer 1, Ribonuclease III |
| Bt03217754_m1 | DNMT1 | DNA (Cytosine-5-)-Methyltransferase 1 |
| Bt03224737_m1 | DNMT3A | DNA (Cytosine-5-)-Methyltransferase 3A |
| Bt01027164_m1 | DNMT3B | DNA (Cytosine-5-)-Methyltransferase 3B |
| Bt03259810_m1 | EGFR | Epidermal growth factor—receptor |
| AJT96D7 | FOXO3 | Forkhead box O3 |
| Bt03649334_s1 | FSHR | Follicle-stimulating hormone receptor |
| Bt03212674_m1 | G6PD | Glucose 6 phosphate desidrogenase |
| Bt03649181_m1 | GADD45A | Growth arrest and DNA-damage-inducible, alpha |
| Bt03225650_m1 | GAPDH | Glyceraldehyde-3-phosphate dehydrogenase |
| Bt03210912_g1 | GDF9 | Growth differentiation factor 9 |
| Bt03223996_m1 | GFPT2 | Glutamine-fructose-6-phosphate transaminase 2 |
| Bt03250351_m1 | GLRX2 | Glutaredoxin 2 |
| Bt03229700_m1 | GPAM | Glycerol-3-phosphate acyltransferase, mitochondrial |
| Bt03210381_m1 | GPX1 | Glutathione peroxidase 1 |
| Bt03259217_g1 | GPX4 | Glutathione peroxidase 4 |
| Bt03259611_m1 | GREM1 | Gremlin 1 |
| Bt03255355_m1 | GSK3A | Glycogen synthase kinase 3 alpha |
| Bt03273695_m1 | H1FOO | H1 histone family, member O, oocyte-specific |
| Bt03228652_g1 | HAS2 | Hyaluronan synthase 2 |
| Bt03212695_g1 | HDAC2 | Histone deacetylase 2 |
| Bt03244871_m1 | HIF1A | Hypoxia inducible factor 1 (transcription factor) |
| Bt03259341_m1 | HSF1 | Heat shock transcription factor 1 |
| Bt03249686_m1 | HSP90AA1 | Heat Shock Protein 90kda Alpha |
| Bt03218068_g1 | HSPA1A | Heat shock 70 kDa protein 1A |
| Bt03292670_g1 | HSPA5 | Glucose-regulated protein, 78 kDa |
| Bt03244880_m1 | HSPD1 | Heat shock 60 kDa protein 1A |
| Bt04301470_g1 | IGF1R | Insulin-like growth factor 1 receptor |
| Bt03649217_m1 | IGF2 | Insulin-like growth factor 2 |
| Bt03259224_m1 | IGFBP2 | Insulin-like growth factor binding protein 2 |
| Bt01040719_m1 | IGFBP4 | Insulin-like growth factor binding protein 4 |
| Bt03259500_m1 | KEAP1 | Kelch-like ECH-associated protein 1 |
| Bt03817661_m1 | LHCGR | Luteinizing hormone/choriogonadotropin receptor |
| Bt03213974_m1 | MAPK1 | Mitogen-activated protein kinase |
| Bt03216718_g1 | MTIF3 | Mitochondrial translational initiation factor 3 |
| Bt03231844_m1 | NANOG | Nanoghomeobox |
| Bt03220541_m1 | NFE2L2 | Nuclear factor (erythroid-derived 2)-like 2 |
| Bt03251880_m1 | NFKB2 | Nuclear factor of kappa light polypeptide gene enhancer in b-cells 2 |
| Bt03272789_g1 | NOS2 | Nitric oxide synthase 2, inducible |
| Bt03249597_m1 | NOS3 | Nitric oxide synthase 3 |
| Bt03217679_m1 | NPPA | Natriuretic peptide A (ANP) |
| Bt03223175_g1 | NPPB | Natriuretic peptide B (BNP) |
| Bt04301375_g1 | NPPC | Natriuretic peptide C (CNP) |
| Bt03212844_m1 | NPR1 | Natriuretic peptide receptor 1 |
| Bt04297034_g1 | NPR2 | Natriuretic peptide receptor 2 |
| Bt04316732_m1 | NPR3 | Natriuretic peptide receptor 3 |
| Bt03212867_m1 | NR1H3 | Nuclear receptor subfamily 1 group H member 3 |
| Bt03218363_m1 | OOSP1 | Oocyte-secreted protein 1 |
| Bt03233533_g1 | PA2G4 | Proliferation-associated 2G4 |
| Bt03211241_g1 | PAF1 | RNA polymerase ii associated factor |
| Bt03239371_g1 | PDE5A | Phosphodiesterase 5A, cGMP-specific |
| Bt03214261_m1 | PFKP | Phosphofructokinase |
| Bt04316551_m1 | PGK1 | Phosphoglycerate kinase 1 |
| Bt03225854_mH | PNPLA2 | Patatin-like phospholipase domain containing 2 |
| Bt03234129_g1 | POU5F1 | POU class 5 homeobox 1 (OCT4) |
| Bt03223846_g1 | PPARA | Peroxisome proliferator-activated receptor alpha |
| Bt03220821_m1 | PPARG | Peroxisome proliferator-activated receptor gamma |
| Bt03217547_m1 | PPARGC1A | Peroxisome proliferator-activated receptor gamma, coactivator 1 alpha |
| Bt01016720_m1 | PPIA | Peptidylprolylisomerase A |
| Bt03224617_g1 | PRDX1 | Peroxiredoxin-1 |
| Bt03223684_m1 | PRDX3 | Peroxiredoxin 3 |
| Bt03214402_m1 | PTGS2/COX2 | Prostaglandin-endoperoxide synthase 2 |
| Bt03214489_m1 | PTX3 | Pentraxin 3, long |
| Bt03249011_m1 | REST | RE1-silencing transcription factor |
| Bt03278318_s1 | RGS2 | Regulator of G-protein signaling 2 |
| Bt03246656_g1 | RPL15 | Ribosomal protein L15 |
| Bt03288449_g1 | SOD1 | Superoxide dismutase 1, soluble |
| Bt03215423_g1 | SOD2 | Superoxide dismutase 2, mitochondrial |
| Bt03244551_m1 | SOX2 | SRY (sex determining region Y)-box 2 |
| Bt03278318_s1 | SREBF1 | Sterol regulatory element binding transcription f1 |
| Bt03276370_m1 | SREBF2 | Sterol regulatory element binding transcription f2 |
| Bt04283467_m1 | STAT3 | Signal transducer and activator of transcription 3 |
| Bt03259871_g1 | TFAM | Transcription factor A, mitochondrial |
| Bt03260078_m1 | TNFAIP6 | Tumor necrosis factor, alpha-induced protein 6 |
| Bt03210223_m1 | TNFRSF21 | Tumor necrosis factor receptor superfamily member 21 |
| Bt03250597_m1 | TP53 | Tumor protein p53 |
| Bt03223213_m1 | VCAN | Versican |
| Bt03217633_m1 | XBP1 | X-box binding protein 1 |
Figure 2Induction of autophagy on COCs submitted to heat shock during IVM. Representative western blotting images of single cropped blots for oocytes and cumulus cells showing both types of LC3 protein (Full-length blots are presented in Supplementary Fig. S1 online) (A). Quantification of LC3-II/LC3-I ratio on oocytes (B) and cumulus cells (C). Results are least-squares means ± SEM. Different letters in each bar represent significant difference (P < 0.05).
Figure 3The impact of autophagy inhibition during IVM of heat-shocked bovine oocytes on the proportion of oocytes that cleaved (A) and developed to the blastocyst stage (B), and the proportion of cleaved embryos that developed to blastocyst (C). Results are least-squares means ± SEM. Different letters in each bar represent significant difference (P < 0.05). The figure was
adapted from Master’s Thesis[83].
Figure 4Effect of autophagy inhibition during IVM of heat-shocked bovine oocytes on mRNA abundance of differentially expressed genes according to the following functional categories: oocyte maturation (A), oocyte competence to embryonic development (B), energy metabolism (C), lipid metabolism (D), and heat shock response (E). Results are least-squares means ± SEM. Different letters in each bar represent significant difference (P ≤ 0.05). †P = 0.06. The figure was
adapted from Master’s Thesis[83].